|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RAPID COMMUNICATIONS |
a Centre for Stem Cell Biology and Developmental Genetics and
b Institute of Human Genetics, University of Newcastle, Newcastle upon Tyne, United Kingdom;
c School of Biological and Biomedical Sciences, University of Durham, Durham, United Kingdom;
d Newcastle Fertility Centre at Life, International Centre for Life, Newcastle upon Tyne, United Kingdom
Key Words. NANOG • Human embryonic stem cells • Pluripotency • Small interfering RNA • Trophectoderm • Primitive endoderm
Correspondence: Majlinda Lako, Ph.D., Centre for Stem Cell Biology and Developmental Genetics, University of Newcastle International Centre for Life, Newcastle NE1 3BZ, United Kingdom. Telephone: 0191-241-8688; Fax: 0191-241-8666; e-mail: Majlinda.Lako{at}ncl.ac.uk
The homeobox transcription factor Nanog has been proposed to play a crucial role in the maintenance of the undifferentiated state of murine embryonic stem cells. A human counterpart, NANOG, has been identified, but its function and localization have not hitherto been described. We have used a combination of RNA interference and quantitative real-time polymerase chain reaction to study NANOG in human embryonic stem and embryonic carcinoma cells. Transfection of NANOG-specific small interfering RNAs reduced levels of NANOG transcript and protein and induced activation of the extraembryonic endoderm-associated genes GATA4, GATA6, LAMININ B1, and AFP as well as upregulation of trophectoderm-associated genes CDX2, GATA2, hCG-alpha, and hCG-beta. Immunostaining of preimplantation human embryos showed that NANOG was expressed in the inner cell mass of expanded blastocysts but not in earlier-stage embryos, consistent with a role in the maintenance of pluripotency. Taken together, our findings suggest that NANOG acts as a gatekeeper of pluripotency in human embryonic stem and carcinoma cells by preventing their differentiation to extraembryonic endoderm and trophectoderm lineages.
This article has been cited by other articles:
![]() |
B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen, and R.A. Keough Understanding pluripotency--how embryonic stem cells keep their options open Mol. Hum. Reprod., September 1, 2008; 14(9): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu and J. A. Thomson Pluripotent stem cell lines Genes & Dev., August 1, 2008; 22(15): 1987 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Van de Velde, G. Cauffman, H. Tournaye, P. Devroey, and I. Liebaers The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm Hum. Reprod., August 1, 2008; 23(8): 1742 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fong, K. A. Hohenstein, and P. J. Donovan Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells Stem Cells, August 1, 2008; 26(8): 1931 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Monk, M. Hitchins, and S. Hawes Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development Mol. Hum. Reprod., June 1, 2008; 14(6): 347 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ullmann, C. Gilles, M. De Rycke, H. Van de Velde, K. Sermon, and I. Liebaers GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions Mol. Hum. Reprod., March 1, 2008; 14(3): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Choudhary, X. Zhang, P. Stojkovic, L. Hyslop, G. Anyfantis, M. Herbert, A. P. Murdoch, M. Stojkovic, and M. Lako Putative Role of Hyaluronan and Its Related Genes, HAS2 and RHAMM, in Human Early Preimplantation Embryogenesis and Embryonic Stem Cell Characterization Stem Cells, December 1, 2007; 25(12): 3045 - 3057. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Lim, Y.-H. Loh, W. Zhang, Y. Li, X. Chen, Y. Wang, M. Bakre, H.-H. Ng, and L. W. Stanton Zic3 Is Required for Maintenance of Pluripotency in Embryonic Stem Cells Mol. Biol. Cell, April 1, 2007; 18(4): 1348 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qin, T. Yu, T. Qing, Y. Liu, Y. Zhao, J. Cai, J. Li, Z. Song, X. Qu, P. Zhou, et al. Regulation of Apoptosis and Differentiation by p53 in Human Embryonic Stem Cells J. Biol. Chem., February 23, 2007; 282(8): 5842 - 5852. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ullmann, P. In't Veld, C. Gilles, K. Sermon, M. De Rycke, H. Van de Velde, A. Van Steirteghem, and I. Liebaers Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions Mol. Hum. Reprod., January 1, 2007; 13(1): 21 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Brimble, E. S. Sherrer, E. W. Uhl, E. Wang, S. Kelly, A. H. Merrill Jr., A. J. Robins, and T. C. Schulz The Cell Surface Glycosphingolipids SSEA-3 and SSEA-4 Are Not Essential for Human ESC Pluripotency Stem Cells, January 1, 2007; 25(1): 54 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cauffman, I. Liebaers, A. Van Steirteghem, and H. Van de Velde POU5F1 Isoforms Show Different Expression Patterns in Human Embryonic Stem Cells and Preimplantation Embryos Stem Cells, December 1, 2006; 24(12): 2685 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hasegawa, T. Fujioka, Y. Nakamura, N. Nakatsuji, and H. Suemori A Method for the Selection of Human Embryonic Stem Cell Sublines with High Replating Efficiency After Single-Cell Dissociation Stem Cells, December 1, 2006; 24(12): 2649 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, P. Stojkovic, S. Przyborski, M. Cooke, L. Armstrong, M. Lako, and M. Stojkovic Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos Stem Cells, December 1, 2006; 24(12): 2669 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-y. Yasuda, N. Tsuneyoshi, T. Sumi, K. Hasegawa, T. Tada, N. Nakatsuji, and H. Suemori NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells, September 1, 2006; 11(9): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al. The role of PI3K/AKT, MAPK/ERK and NF{kappa}{beta} signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis Hum. Mol. Genet., June 1, 2006; 15(11): 1894 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Hough, I. Clements, P. J. Welch, and K. A. Wiederholt Differentiation of Mouse Embryonic Stem Cells after RNA Interference-Mediated Silencing of OCT4 and Nanog Stem Cells, June 1, 2006; 24(6): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nganvongpanit, H. Muller, F. Rings, M. Hoelker, D. Jennen, E. Tholen, V. Havlicek, U. Besenfelder, K. Schellander, and D. Tesfaye Selective degradation of maternal and embryonic transcripts in in vitro produced bovine oocytes and embryos using sequence specific double-stranded RNA. Reproduction, May 1, 2006; 131(5): 861 - 874. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
